← Leaderboards
Kohei Hasegawa
Massachusetts General Hospital
$9,759,240
Attributed
$10,702,868
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2015–22$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,702,868 · 4
By mechanism
R01$10,196,996 · 3
R21$505,872 · 1
Top collaborators
- Liming Liang3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Douglas Kwon$11,694,140
- Zhaozhong Zhu$3,844,178
- David A Drew$792,600
- Shiv Subramaniam Pillai$21,368,359
- Long H Nguyen$1,000,500
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelUnited States National Institutes Of HealthPrimary PreventionMedical RecordsInnovationHigh RiskLinkParentsChildhood AsthmaLung DevelopmentEnrollmentAfrican AmericanCohortBronchiolitisInfantFollow-UpCollaborationsInterviewChildAsthmaChildhoodFundingCohort StudiesEvidence Base
Grant awards (15)
Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort$807,865
R01 · FY2022 · AI · contact PI
Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort$709,514
R01 · FY2022 · AI · contact PI
Infant blood epigenome and risks of IgE sensitization, obesity, and asthma: MARC-35/43 cohorts$629,085
R01 · FY2022 · AI
Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort$951,272
R01 · FY2021 · AI · contact PI
Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort$687,052
R01 · FY2021 · AI · contact PI
Infant blood epigenome and risks of IgE sensitization, obesity, and asthma: MARC-35/43 cohorts$629,086
R01 · FY2021 · AI
Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort$822,335
R01 · FY2020 · AI · contact PI
Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort$687,403
R01 · FY2020 · AI · contact PI
Infant blood epigenome and risks of IgE sensitization, obesity, and asthma: MARC-35/43 cohorts$629,086
R01 · FY2020 · AI
Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort$1,044,092
R01 · FY2019 · AI · contact PI
Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort$843,082
R01 · FY2019 · AI · contact PI
Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort$887,528
R01 · FY2018 · AI · contact PI
Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort$869,596
R01 · FY2018 · AI · contact PI
Cytokines & transcriptomes in rhinovirus bronchiolitis and risk of incident asthma$254,986
R21 · FY2016 · HL · contact PI
Cytokines & transcriptomes in rhinovirus bronchiolitis and risk of incident asthma$250,886
R21 · FY2015 · HL · contact PI